Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Myeloma

NCT07087964 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT07087964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07087964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Myeloma
Lead sponsor
Universiteit Antwerpen
Phase
Observational
Overall status
Recruiting
Start date
May 16, 2022
Completion date
December 31, 2028
Enrollment
120 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed multiple myeloma (ndmm)